Yamamoto Y, Kawashima A, Kashiwagi E, Ogata K.
A Jehovah's Witness with acute myeloid leukemia (AML) successfully treated with an epigenetic drug, azacitidine: A clue for development of anti-AML
therapy requiring minimum blood transfusions. (Submitted)
2014年
Porwit A, van de Loosdrecht AA, Bettelheim P, Brodersen LE, Burbury K, Cremers E, Della Porta MG, Ireland R, Johansson U, Matarraz S, Ogata K,
Orfao A, Preijers F, Psarra K, Subira D, Valent P, van der Velden VH, Wells D, Westers TM, Kern W, Bene MC. Revisiting guidelines for integration of flow cytometry results in the
WHO classification of myelodysplastic syndromes-proposal from the International/European
LeukemiaNet Working Group for Flow Cytometry in MDS.
Leukemia 2014 (in press)
2014年
Della Porta MG, Picone C, Tenore A, Yokose N, Malcovati L, Cazzola M, Ogata K. Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia.
Haematologica 2014 99:e8-10
2013年８月号
Okuyama N, Sperr WR, Kadar K, Bakker S, Szombath G, Handa H, Tamura H,Kondo A, Valent P, Várkonyi J, van de Loosdrecht A, Ogata K.
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes:
A multicenter retrospective study.
Leuk Res. 2013 37:862-7.
2013年７月号
Ueda Y, Mizutani C, Nannya Y, Kurokawa M, Kobayashi S, Takeuchi J, Tamura H, Ogata K, Dan K, Shibayama H, Kanakura Y, Niimi K, Sasaki K, Watanabe
M, Emi N, Teramura M, Motoji T, Kida M, Usuki K, Takada S, Sakura T, Ito Y, Ohyashiki K, Ogawa H, Suzuki T, Ozawa K, Imai K, Kasai M, Hata T, Miyazaki
Y, Morita Y, Kanamaru A, Matsuda A, Tohyama K, Koga D, Tamaki H, Mitani K, Naoe T, Sugiyama H, Takaku F.
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and
bone marrow in patients with myelodysplastic syndromes.
Leuk Lymphoma. 2013 54:1450-8.
2013年3月号
van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS, Bettelheim P, Bowen DT, Burbury K, Eidenschink L, Cazzola M,
Chu SS, Cullen M, Cutler JA, Dräger AM, Feuillard J, Fenaux P, Font P, Germing U, Haase D, Hellström-Lindberg E, Johansson U, Kordasti S, Loken MR,
Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Nikolova V, Ogata K, Oelschlaegel U, Orfao A, Ossenkoppele GJ, Porwit A, Platzbecker U,
Preijers F, Psarra K, Richards SJ, Subirá D, Seymour JF, Tindell V, Vallespi T, Valent P, van der Velden VH, Wells DA, de Witte TM, Zettl F, Béné MC, Westers TM.
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.
Leuk Lymphoma. 2013 54:472-5.
2013年2月号
Tamura H, Ishibashi M, Yamashita T, Tanosaki S, Okuyama N, Kondo A, Hyodo
H, Shinya E, Takahashi H, Dong H, Tamada K, Chen L, Dan K, Ogata K.
Marrow stromal cells induce B7-H1 expression on myeloma cells, generating
aggressive characteristics in multiple myeloma.
Leukemia. 2013 47;464-472.
本年の実績（学会発表）
The 12th international Symposium on Myelodysplastic Syndromes. May 8-13, 2013. Berlin, Germany
CD7 expression on MDS blasts is associated with apoptosis resistance with decreased levels of the apoptosis-related protein Bad.
N. Okuyama, H. Tamura, N. Kamei, M. Ishibashi, Y. Hamada, A. Kondo, K. Moriya, K. Ogata
Clinical significance of the interleukin-2 receptor alpha-chain expressed by blasts in myelodysplastic syndromes
M. Ishibashi, H. Tamura, K. Ogata
Flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group
T.M. Westers, W. Kern, R. Ireland, M.C. Béné, M.G. Della Porta, K. Ogata, A.A. Van de Loosdrecht